Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

13 filings reported holding ACST - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.15M shares of 15.5M outstanding shares and own 13.89% of the company stock.
Largest 10 shareholders include ADAR1 Capital Management, LLC (960K shares), AIGH Capital Management LLC (641K shares), BANK OF AMERICA CORP /DE/ (495K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (37.8K shares), UBS Group AG (7.74K shares), Royal Bank of Canada (6.58K shares), NATIONAL BANK OF CANADA /FI/ (2.9K shares), MORGAN STANLEY (1.88K shares), Activest Wealth Management (104 shares), and Federation des caisses Desjardins du Quebec (28 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.